Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 11, 2023
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
[ Fri, Aug 11th 2023
] - WOPRAI
Richard Law Reiterated (VERV) at Hold and Held Target at $31 on, Aug 11th, 2023
Richard Law of Credit Suisse, Reiterated "Verve Therapeutics, Inc." (VERV) at Hold and Held Target at $31 on, Aug 11th, 2023.
Richard has made no other calls on VERV in the last 4 months.
There are 2 other peers that have a rating on VERV. Out of the 2 peers that are also analyzing VERV, 0 agree with Richard's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Richard
- Whitney Ijem of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $29 on, Friday, June 16th, 2023
- Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Tuesday, May 16th, 2023
